S21-064 Synthesis of EBC-46 (tigilanol tiglate) and Analogs for Treatment of Cancer and Other PKC-related Diseases Stanford scientists in Dr. Paul Wender's lab have developed a novel method to synthesize tigilanol tiglate (EBC-46) and related compounds from readily available starting materials. Paul Wender Nguyen Hong Quang Luu Zach Gentry Edward Njoo David Fanelli Owen Dennis McAteer